About
Josh Pan, PhD, MBA is a biotech executive and venture operator focused on drug development, corporate strategy, and venture support. Public bios place him as a Partner at Bellevue Capital Management, Venture Partner at OSR Holdings, and Chief Corporate Development Officer at Landmark BioVentures. He previously worked at Athira Pharma through its IPO period and earlier served in operating roles at W Fund.
Areas of interest
biotechdrug developmentoncologyglioblastomaneurodegenerative diseasesAlzheimer's diseaseParkinson's diseaseventure capitalcorporate developmentbusiness developmentstartup strategy